• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管风险评分的主要局限性。

Major Limitations of Cardiovascular Risk Scores.

机构信息

Laboratory of Health Sciences and Technologies, Higher Institute of Health Sciences of Settat, Hassan First University of Settat, Settat, Morocco.

出版信息

Cardiovasc Ther. 2024 Feb 28;2024:4133365. doi: 10.1155/2024/4133365. eCollection 2024.

DOI:10.1155/2024/4133365
PMID:38449908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10917477/
Abstract

. Epidemiological studies conducted in extensive population cohorts have led to the creation of numerous cardiovascular risk predictor models. However, these tools have certain limitations that restrict its applicability. The aim behind the following work is to summarize today's best-known limitations of cardiovascular risk assessment models through presenting the critical analyses conducted in this area, with the intention of offering practitioners a comprehensive understanding of these restrictions. Critical analyses revealed that these scales exhibit numerous limitations that could impact their performance. Most of these models evaluate cardiovascular risk based on classic risk factors and other restrictions, thereby negatively affecting their sensitivity. Scientists have made significant advancements in improving cardiovascular risk models, tailoring them to accommodate a wide range of populations and devising scales for estimating cardiovascular risks that can account for all prevailing restrictions. Better understanding these limitations could improve the cardiovascular risk stratification.

摘要

. 广泛的人群队列中的流行病学研究导致了许多心血管风险预测模型的创建。然而,这些工具存在一定的局限性,限制了其适用性。以下工作的目的是通过对该领域进行的批判性分析,总结当今最知名的心血管风险评估模型的局限性,旨在为从业者提供对这些限制的全面理解。批判性分析表明,这些量表存在许多限制,可能会影响它们的性能。这些模型中的大多数都是基于经典的风险因素和其他限制来评估心血管风险的,从而降低了它们的敏感性。科学家们在改进心血管风险模型方面取得了重大进展,使它们能够适应广泛的人群,并制定出能够考虑到所有现有限制的估计心血管风险的量表。更好地理解这些局限性可以改善心血管风险分层。

相似文献

1
Major Limitations of Cardiovascular Risk Scores.心血管风险评分的主要局限性。
Cardiovasc Ther. 2024 Feb 28;2024:4133365. doi: 10.1155/2024/4133365. eCollection 2024.
2
Predictive performance of established cardiovascular risk scores in the prediabetic population: external validation using the UK Biobank data set.既定心血管风险评分在糖尿病前期人群中的预测性能:使用英国生物银行数据集进行外部验证
Eur J Prev Cardiol. 2023 Oct 10;30(14):1427-1438. doi: 10.1093/eurjpc/zwad106.
3
New approaches for improving cardiovascular risk assessment.改善心血管风险评估的新方法。
Rev Port Cardiol. 2016 Jan;35(1):5-13. doi: 10.1016/j.repc.2015.10.006. Epub 2015 Dec 29.
4
Incremental value of the measures of arterial stiffness in cardiovascular risk assessment.动脉僵硬度指标在心血管风险评估中的增量价值。
Rev Cardiovasc Med. 2022 Jan 11;23(1):6. doi: 10.31083/j.rcm2301006.
5
Improving risk stratification in people with previous manifestations of cardiovascular disease: one size does not fit all in secondary prevention.改善有心血管疾病既往表现者的风险分层:二级预防中不存在适用于所有人的单一方案。
Eur J Prev Cardiol. 2024 Jan 25;31(2):216-217. doi: 10.1093/eurjpc/zwad334.
6
Cardiovascular disease risk communication in NHS Health Checks using QRISK®2 and JBS3 risk calculators: the RICO qualitative and quantitative study.使用 QRISK®2 和 JBS3 风险计算器在国民保健制度健康检查中进行心血管疾病风险沟通: RICO 定性和定量研究。
Health Technol Assess. 2021 Aug;25(50):1-124. doi: 10.3310/hta25500.
7
Cardiovascular risk stratification in young women: the pivotal role of pregnancy.年轻女性的心血管风险分层:妊娠的关键作用。
J Cardiovasc Med (Hagerstown). 2023 Nov 1;24(11):793-797. doi: 10.2459/JCM.0000000000001557. Epub 2023 Sep 29.
8
Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertension.新的心血管风险评估策略在高危高血压患者中的优势。
Clin Ther. 2005 Oct;27(10):1658-68. doi: 10.1016/j.clinthera.2005.10.013.
9
Cardiovascular risk prediction: from classical statistical methods to machine learning approaches.心血管风险预测:从经典统计学方法到机器学习方法。
Minerva Cardiol Angiol. 2022 Feb;70(1):102-122. doi: 10.23736/S2724-5683.21.05868-3.
10
Focus on population studies in cardiovascular risk assessment.关注心血管风险评估中的人群研究。
Eur J Prev Cardiol. 2024 Jan 5;31(1):1-2. doi: 10.1093/eurjpc/zwad371.

引用本文的文献

1
A proposed model using glycation metrics and circulating biomarkers for the prevention of cardiovascular disease.一种使用糖基化指标和循环生物标志物预防心血管疾病的模型。
Front Med (Lausanne). 2025 Aug 12;12:1624682. doi: 10.3389/fmed.2025.1624682. eCollection 2025.
2
Saudi Heart Association Position Statement on Troponin use for Cardiovascular Risk Screening in Asymptomatic Populations.沙特心脏协会关于肌钙蛋白用于无症状人群心血管风险筛查的立场声明。
J Saudi Heart Assoc. 2025 Jul 16;37(3):10. doi: 10.37616/2212-5043.1444. eCollection 2025.
3
Coronary CT angiography evaluation with artificial intelligence for individualized medical treatment of atherosclerosis: a Consensus Statement from the QCI Study Group.基于人工智能的冠状动脉CT血管造影评估在动脉粥样硬化个体化医疗中的应用:QCI研究组共识声明
Nat Rev Cardiol. 2025 Aug 1. doi: 10.1038/s41569-025-01191-6.
4
Evaluating the potential of phenotypic age to enhance cardiovascular risk prediction over chronological age in the UK Biobank.在英国生物银行中评估表型年龄相较于实际年龄增强心血管疾病风险预测的潜力。
Sci Rep. 2025 Jul 30;15(1):27858. doi: 10.1038/s41598-025-12495-5.
5
Why, how and in whom should we measure levels of lipoprotein(a): A review of the latest evidence and clinical implications.我们为何、如何以及对谁进行脂蛋白(a)水平检测:最新证据及临床意义综述
Diabetes Obes Metab. 2025 May 28. doi: 10.1111/dom.16469.
6
Opportunities and Challenges of Cardiovascular Disease Risk Prediction for Primary Prevention Using Machine Learning and Electronic Health Records: A Systematic Review.利用机器学习和电子健康记录进行心血管疾病一级预防风险预测的机遇与挑战:一项系统综述
Rev Cardiovasc Med. 2025 Apr 25;26(4):37443. doi: 10.31083/RCM37443. eCollection 2025 Apr.
7
Troponin Testing for Cardiovascular Primary Prevention Decision Making?肌钙蛋白检测用于心血管疾病一级预防的决策制定?
J Am Coll Cardiol. 2025 Apr 15;85(14):1485-1487. doi: 10.1016/j.jacc.2025.02.026.
8
Non-Invasive Assessment of Vascular Damage Through Pulse Wave Velocity and Superb Microvascular Imaging in Pre-Dialysis Patients.通过脉搏波速度和超微血管成像对透析前患者血管损伤进行无创评估。
Biomedicines. 2025 Mar 4;13(3):621. doi: 10.3390/biomedicines13030621.
9
Relevance of longer-term outcome measures in the assessment of cardiovascular risk.长期结局指标在心血管风险评估中的相关性。
Open Heart. 2025 Mar 25;12(1):e003176. doi: 10.1136/openhrt-2025-003176.
10
Assessment of heart rate measurements by commercial wearable fitness trackers for early identification of metabolic syndrome risk.利用商用可穿戴健身追踪器评估心率测量值,以早期识别代谢综合征风险。
Sci Rep. 2024 Oct 12;14(1):23865. doi: 10.1038/s41598-024-74619-7.

本文引用的文献

1
Cardiovascular Risk Prediction Models and Scores in the Era of Personalized Medicine.个性化医疗时代的心血管疾病风险预测模型与评分
J Pers Med. 2022 Jul 20;12(7):1180. doi: 10.3390/jpm12071180.
2
Framingham Heart Study: JACC Focus Seminar, 1/8.弗雷明汉心脏研究:美国心脏病学会焦点研讨会,1/8。
J Am Coll Cardiol. 2021 Jun 1;77(21):2680-2692. doi: 10.1016/j.jacc.2021.01.059.
3
External validation of three atherosclerotic cardiovascular disease risk equations in rural areas of Xinjiang, China.中国新疆农村地区三个动脉粥样硬化性心血管疾病风险方程的外部验证
BMC Public Health. 2020 Sep 29;20(1):1471. doi: 10.1186/s12889-020-09579-4.
4
Estimation of total cardiovascular risk using the 2019 WHO CVD prediction charts and comparison of population-level costs based on alternative drug therapy guidelines: a population-based study of adults in Bangladesh.采用 2019 年世卫组织 CVD 预测图表估算全因心血管风险,并基于替代药物治疗指南比较基于人群的成本:孟加拉国成年人的一项基于人群的研究。
BMJ Open. 2020 Jul 19;10(7):e035842. doi: 10.1136/bmjopen-2019-035842.
5
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions.世界卫生组织心血管疾病风险图表:修订后的模型可估算 21 个全球区域的风险。
Lancet Glob Health. 2019 Oct;7(10):e1332-e1345. doi: 10.1016/S2214-109X(19)30318-3. Epub 2019 Sep 2.
6
Cardiovascular Disease and the Female Disadvantage.心血管疾病与女性劣势。
Int J Environ Res Public Health. 2019 Apr 1;16(7):1165. doi: 10.3390/ijerph16071165.
7
Comparison of Recommendations and Use of Cardiovascular Risk Equations by Health Technology Assessment Agencies and Clinical Guidelines.比较心血管风险评估方程的推荐意见和使用情况 健康技术评估机构和临床指南。
Value Health. 2019 Feb;22(2):210-219. doi: 10.1016/j.jval.2018.08.003. Epub 2018 Sep 21.
8
External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.澳大利亚糖尿病、肥胖和生活方式研究的数据对四种心血管风险预测模型的外部验证和比较。
Med J Aust. 2019 Mar;210(4):161-167. doi: 10.5694/mja2.12061. Epub 2019 Jan 18.
9
Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: an overview of systematic reviews.使用心血管风险评分进行心血管疾病一级预防常规风险评估的效果:系统评价概述。
BMC Cardiovasc Disord. 2019 Jan 9;19(1):11. doi: 10.1186/s12872-018-0990-2.
10
Cardiovascular risk prediction models for women in the general population: A systematic review.一般人群中女性心血管风险预测模型:系统评价。
PLoS One. 2019 Jan 8;14(1):e0210329. doi: 10.1371/journal.pone.0210329. eCollection 2019.